SCHEMBL8029547

SCHEMBL8029547

Cn1c(Cc2ccc(C#N)cc2)nc2cc(NS(=O)(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc21

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
F2 P00734 7/20 0.54
RORC P51449 1/20 0.47
BRPF1 P55201 5/20 0.46
BRD1 O95696 4/20 0.46
BRPF3 Q9ULD4 3/20 0.46
BRD4 O60885 2/20 0.46
BRD9 Q9H8M2 2/20 0.46
PKM P14618 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
BRD7 Q9NPI1 1/20 0.45
LMNA P02545 2/20 0.45
POLB P06746 1/20 0.44
PAX8 Q06710 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8027058 0.86 F2 (0.70) F2BRPF1BRD1BRPF3BRD4
Hydrochloric Acid SCHEMBL8028262 0.83 F2 (0.75) F2RORCPKMSMN1; SMN2LMNA
SCHEMBL8032270 0.83 F2 (0.72) F2BRPF1BRD1BRPF3BRD4
SCHEMBL8027395 0.83 F2 (0.52) F2BRPF1BRD1BRPF3BRD4
SCHEMBL8028365 0.82 F2 (0.73) F2BRPF1BRD1BRPF3BRD4
SCHEMBL8029858 0.81 F2 (0.51) F2BRPF1BRD1BRPF3BRD4
SCHEMBL8016259 0.81 F2 (0.58) F2BRPF1BRD1BRPF3BRD4
SCHEMBL8016793 0.80 F2 (0.59) F2BRPF1BRD1BRPF3BRD4
SCHEMBL8029978 0.79 F2 (0.60) F2BRPF1BRD1BRPF3BRD4
SCHEMBL8026422 0.79 F2 (0.55) F2BRPF1BRD1BRPF3BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1060166-A1 FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS Boehringer Ingelheim Pharma KG (DE) 2000-12-20 EP disclosed
US-6114532-A ANTICOAGULANT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-05 US disclosed
WO-1999040072-A1 FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-08-12 WO disclosed